Radcliffe Capital Management, L.P. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 58 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$2,049,775
+1.8%
202,9500.0%0.06%
+32.7%
Q3 2022$2,014,000
+0.2%
202,9500.0%0.05%
+6.5%
Q2 2022$2,009,000
+0.4%
202,9500.0%0.05%
+2.2%
Q1 2022$2,001,000
+0.2%
202,9500.0%0.04%
-13.5%
Q4 2021$1,997,000
+1.0%
202,9500.0%0.05%
-10.3%
Q3 2021$1,977,000
+0.7%
202,9500.0%0.06%
-4.9%
Q2 2021$1,963,000202,9500.06%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2022
NameSharesValueWeighting ↓
Kingstown Capital 300,000$72,0000.11%
Telemetry Investments, L.L.C. 153,694$36,0000.06%
Kamunting Street Capital Management, L.P. 158,962$38,0000.05%
Radcliffe Capital Management, L.P. 202,950$2,001,0000.04%
Q Global Advisors, LLC 300,000$72,0000.04%
Integrity Capital Management (HK) Ltd 33,267$8,0000.04%
Corbin Capital Partners, L.P. 464,062$111,0000.02%
HGC Investment Management Inc. 1,215,782$292,0000.02%
Segantii Capital Management Ltd 50,000$493,0000.01%
Sage Rock Capital Management LP 286,900$69,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders